Citation Impact

Citing Papers

Bacteremia Associated With Toothbrushing and Dental Extraction
2008 Standout
The Epidemiology of Heart Failure, Based on Data for 2.1 Million Inhabitants in Sweden
2013
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Ageing populations: the challenges ahead
2009 Standout
Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study
1999
A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
2002 Standout
Renal transplantation following previous heart, liver, and lung transplantation: An 8-year single-center experience
2001
Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials
2003 Standout
Long-Term Trends in the Incidence of and Survival with Heart Failure
2002 Standout
The prognosis of heart failure in the general population. The Rotterdam Study
2001
Economics of elective coronary revascularization
1993
Comparison of Coronary-Artery Bypass Surgery and Stenting for the Treatment of Multivessel Disease
2001
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
Relationships Between Authors of Clinical Practice Guidelines and the Pharmaceutical Industry
2002 Standout
Cross-cultural adaptation of health-related quality of life measures: Literature review and proposed guidelines
1993 Standout
Long-Term Benefit of Primary Angioplasty as Compared with Thrombolytic Therapy for Acute Myocardial Infarction
1999
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Heart failure and the aging population: an increasing burden in the 21st century?
2002
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
2007 Standout
Predictors of renal function following lung or heart-lung transplantation
2002
Quality of life bibliography and indexes: 1993 update
1995
Guidelines on Prevention, Diagnosis and Treatment of Infective Endocarditis Executive Summary The Task Force on Infective Endocarditis of the European Society of Cardiology
2004 Standout
Renal Failure in the Recipients of Nonrenal Solid Organ Transplants
1999
Chronic renal failure after cardiac transplantation: predictive factors and influence on mortality-results of a monocenter study in 141 patients
2002
A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery Disease
1994 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapy
1996
Assessment of Quality-of-Life Outcomes
1996 Standout
A critical appraisal of the quality of the management of infective endocarditis
1999
Social Relationships and Mortality Risk: A Meta-analytic Review
2010 Standout
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial
2003 Standout
Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention
2009 Standout
Multi-Ethnic Study of Atherosclerosis: Objectives and Design
2002 Standout
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
Mortality Risk Reduction Associated With Smoking Cessation in Patients With Coronary Heart Disease
2003
Pre-operative renal function predicts development of chronic renal insufficiency after orthotopic heart transplantation
2002
The Development of a Simulation Model of the Treatment of Coronary Heart Disease
2002
Prevention of Heart Failure
2008
Trends in Heart Failure Incidence and Survival in a Community-Based Population
2004 Standout
Cardiorenal Syndrome
2008 Standout
RISKS AND COSTS OF END-STAGE RENAL DISEASE AFTER HEART TRANSPLANTATION1,2
1998
Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy
2013 Standout
Cytochrome P450 3A5 expression in the kidneys of patients with calcineurin inhibitor nephrotoxicity
2007
Prevention of Infective Endocarditis
1995
Treatment of Hypertension in Patients 80 Years of Age or Older
2008 Standout
Cyclosporin nephrotoxicity in heart and lung transplant patients
1996
Effects of Oral Tolvaptan in Patients Hospitalized for Worsening Heart Failure<SUBTITLE>The EVEREST Outcome Trial</SUBTITLE>
2007 Standout
Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals
2017 Standout
Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000
2007 Standout
Obesity and the Risk of Heart Failure
2002 Standout
Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population
1997
Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)
1998
Congestive Heart Failure in the Community
1999
Epidemiology and risk profile of heart failure
2010
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
2006 Standout
Calcineurin Inhibitor–Induced Nephrotoxicity and Renal Expression of P‐glycoprotein
2005
Predicting Mortality Among Patients Hospitalized for Heart Failure
2003 Standout
Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)
2005 Standout
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Infective endocarditis
2004 Standout
Prophylactic Administration of Penicillins for Endocarditis Does Not Reduce the Incidence of Postextraction Bacteremia
1993
The Impact of Transforming Growth Factor-β1 Gene Polymorphism on End-Stage Renal Failure After Heart Transplantation
2006
Burden of Systolic and Diastolic Ventricular Dysfunction in the Community
2003 Standout
Trends in hospitalization for heart failure in Scotland, 1990–1996. An epidemic that has reached its peak?
2001
Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling
2000 Standout
Sympathetic Neural Mechanisms of Cyclosporine-Induced Hypertension*
1996
The current cost of heart failure to the National Health Service in the UK
2002
Readmission After Hospitalization for Congestive Heart Failure Among Medicare Beneficiaries
1997
Superior Cardiovascular Effect of Aerobic Interval Training Versus Moderate Continuous Training in Heart Failure Patients
2007 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
The Recent Decline in Mortality From Coronary Heart Disease, 1980-1990<subtitle>The Effect of Secular Trends in Risk Factors and Treatment</subtitle>
1997
Serology and Genetics of the DL‐A System. I. Establishment of Specificities
1973 StandoutNobel
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Bone-Marrow Transplantation
1975 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Congestive Heart Failure in the Community
1998
Cyclosporine A-induced hypertension involves synapsin in renal sensory nerve endings
2000 StandoutNobel
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Clinical End Points in Coronary Stent Trials
2007 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
2001 Standout
Deaths from heart failure in general practice: implications for palliative care
2002
The burden of heart failure
2002
The incidence of end-stage renal failure in 17 years of heart transplantation: a single center experience
2002
Trends in the Health of the Elderly
2004
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Change in the Prevalence of Diseases Among Older Americans: 1984-1994
2000
ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina11This document was approved by the American College of Cardiology Board of Trustees in March 1999, the American Heart Association Science Advisory and Coordinating Committee in March 1999, and the American College of Physicians-American Society of Internal Medicine Board of Regents in February 1999.When citing this document, please use the following citation format: Gibbons RJ, Chatterjee K, Daley J, Douglas JS, Fihn SD, Gardin JM, Grunwald MA, Levy D, Lytle BW, O’Rourke RA, Schafer WP, Williams SV. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 1999;33:2092–197.This document is available on the World Wide Web sites of the American College of Cardiology (www.acc.org) and the American Heart Association (www.americanheart.org). Reprints of this document are available by calling 1-800-253-4636 or writing the American College of Cardiology, Educational Services, at 9111 Old Georgetown Road, Bethesda, MD 20814-1699. Ask for reprint number 71-0166. To obtain a reprint of the Executive Summary and Recommendations published in the June 1, 1999 issue of Circulation, ask for reprint number 71-0167. To purchase bulk reprints (specify version and reprint number): Up to 999 copies call 1-800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies call 214-706-1466, fax 214-691-6342, or e-mail pubauth@heart.org
1999
The burden of heart failure
2003
Weekend versus Weekday Admission and Mortality from Myocardial Infarction
2007 Standout
In-Hospital Cost of Percutaneous Coronary Revascularization
1995

Works of K Meeter being referenced

Time Course of the Decline in Renal Function in Cyclosporine-Treated Heart Transplant Recipients
1994
Compliance with the medical regimen and partner's quality of life after heart transplantation
1993
Estimating clinical morbidity due to ischemic heart disease and congestive heart failure: the future rise of heart failure.
1994
Smoking cessation reduces mortality after coronary artery bypass surgery: a 20-year follow-up study
2000
Histocompatibility in orthotopic heart transplantation in dogs.
1971
Efficacy of nicorandil versus propranolol in mild stable angina pectoris of effort: a long-term, double-blind, randomized study.
1992
Prophylaxis of infective endocarditis for dental procedures Report of a Working party of the European Society of Cardiology*
1985
Comparison of costs of percutaneous transluminal coronary angioplasty and coronary bypass surgery for patients with angina pectoris
1990
Rankless by CCL
2026